Fidelity Covington Trust’s Fidelity MSCI Health Care index ETF held $3,288,587,081.94 in net Assets as of July 31, with AbbVie valued at $211,140,414.12 and Abbott Laboratories at $87,572,555.70. The snapshot gives investors the fund’s reported asset base and the disclosed weights of its leading positions.
Key Highlights
- AbbVie represented 6.42% of the Fidelity MSCI Health Care Index ETF’s net assets.
- Abbott Laboratories accounted for 2.66% of the portfolio.
- ADMA Biologics was listed with 104,878 shares valued at $887,267.88.
AbbVie (NYSE: ABBV) carried a reported portfolio weight of 6.42%, while Abbott Laboratories (NYSE: ABT) represented 2.66%. The portfolio record identifies the Investment vehicle as Fidelity MSCI Health Care Index ETF and gives July 31 as the reporting date.
AbbVie and Abbott Positions
Its reported allocation was 6.42%. Its reported portfolio share was 2.66%. Other disclosed positions included Acadia Healthcare Co Inc, with 37,176 shares valued at $1,101,153.12 ($1.1 million), representing 0.03%. The holdings record also listed ACADIA Pharmaceuticals Inc (NASDAQ: ACAD) with 54,681 shares valued at $1,414,597.47 and a 0.04% allocation.
Additional Healthcare Holdings
ADMA Biologics Inc (NASDAQ: ADMA) was listed with 104,878 shares valued at $887,267.88, equal to 0.03% of the portfolio. AMN Healthcare Services Inc (NYSE: AMN) had 18,596 shares worth $625,383.48, representing 0.02%. ANI Pharmaceuticals Inc was recorded with 8,812 shares valued at $698,262.88, or 0.02% of the fund. The portfolio also included Adaptive Biotechnologies Corp (NASDAQ: ADPT), with 55,701 shares valued at $1,257,171.57 and a 0.04% allocation. Addus HomeCare Corp (NASDAQ: ADUS) was listed with 8,692 shares valued at $1,003,752.16, representing 0.03%. Spyre Therapeutics Inc had 26,643 shares valued at $2,619,806.19 and a 0.08% weighting.



Please wait processing your request...